The DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.
Liposomes as nanomedical devices
Open accessAbstract
Since their discovery in the 1960s, liposomes have been studied in depth, and they continue to constitute a field of intense research. Liposomes are valued for their biological and technological advantages, and are considered to be the most successful drug-carrier system known to date. Notable progress has been made, and several biomedical applications of liposomes are either in clinical trials, are about to be put on the market, or have already been approved for public use. In this review, we briefly analyze how the efficacy of liposomes depends on the nature of their components and their size, surface charge, and lipidic organization. Moreover, we discuss the influence of the physicochemical properties of liposomes on their interaction with cells, half-life, ability to enter tissues, and final fate in vivo. Finally, we describe some strategies developed to overcome limitations of the "first-generation" liposomes, and liposome-based drugs on the market and in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–212 of 212
Identification of proteins mediating clearance of liposomes using a liver perfusion system
Harashima, H., Matsuo, H., & Kiwada, H. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00132-4 · Cited by 44
Enhanced efficacy of pH-sensitive nystatin liposomes against Cryptococcus neoformans in murine model
Nasti, T. H., Khan, M. A., & Owais, M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki454 · Cited by 42
Overcoming obstacles to develop effective and safe siRNA therapeutics
Li, L., & Shen, Y. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590902911420 · Cited by 41
Wu, H., Ramanathan, R. K., Zamboni, B. A., Strychor, S., Ramalingam, S. S., Edwards, R. P., Friedland, D., Stoller, R. G., Belani, C. P., Maruca, L. J., et al. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010394851 · Cited by 39
Silverman, J. A., Reynolds, L., & Deitcher, S. R. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.155 · Cited by 38
Arlinghaus, R. B., Lopez‐Berestein, G., Belmont, J. W., Rosenblum, M. G., Sun, T., Stephens, C. L., Monaco, G., Gutiérrez-Puente, Y., & Tari, A. M. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.5.1243 · Cited by 38
Katsumata, N., Fujiwara, Y., Kamura, T., Nakanishi, T., Hatae, M., Aoki, D., Tanaka, K., Tsuda, H., Kamiura, S., Takehara, K., et al. (2008) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyn101 · Cited by 37
Preclinical and clinical studies of anticancer drug-incorporated polymeric micelles
Matsumura, Y. (2007) · Journal of drug targeting · doi:10.1080/10611860701499888 · Cited by 37
m‐THPC‐mediated photodynamic therapy of malignant gliomas: Assessment of a new transfection strategy
Molinari, A., Bombelli, C., Mannino, S., Stringaro, A., Toccacieli, L., Calcabrini, A., Colone, M., Mangiola, A., Maira, G., Luciani, P., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22793 · Cited by 34
Self-citationA novel vaccine adjuvant for recombinant flu antigens
Chang, S., Warner, J. F., Liang, L. R., & Fairman, J. (2009) · Biologicals · doi:10.1016/j.biologicals.2009.02.019 · Cited by 28
Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules
Herringson, T. P., & Altin, J. G. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.06.034 · Cited by 27
Liposomes: Design and Manufacturing
Patil, S. D., & Burgess, D. J. (2005) · CRC Press eBooks · doi:10.1201/9780849350610-12 · Cited by 11
Cited by
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Advances and Challenges of Liposome Assisted Drug Delivery
Sercombe, L., Veerati, T., Moheimani, F., Wu, S. Y., Sood, A. K., & Hua, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00286 · Cited by 2,632
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Liposomes: Structure, composition, types, and clinical applications
Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09394 · Cited by 1,561
Design of liposomes as drug delivery system for therapeutic applications
Guimarães, D., Cavaco-Paulo, A., & Nogueira, E. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120571 · Cited by 1,196
Metadata
- Authors
- Bozzuto, G., & Molinari, A.
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2015-02
- Volume
- 10
- Pages
- 975
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W2051925512
- Cited by
- 2,261
- References
- 212
- FWCI
- 44.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.